Quoin Pharmaceuticals Ltd.

QNRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$6.90

-$0.16 (-2.27%)

At close: Sep 21, 2026, 4:00 PM ET

$7.23

+$0.33 (+4.78%)

After-hours: Sep 21, 2026, 7:34 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-2.27%

(1D)

Rating

Updated: Aug 13, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $13.86M

1D Range

6.68 7.14

52W Range

3.25 41.80

Valuation (TTM)

PE -0.49

PB 3.52

EV/EBITDA -0.16

Valuation (NTM)

Forward PE N/A

Forward PEG 0.01

Price Target N/A

Cash Flow

FCF Yield -111.1%

SBC Adj. FCF Yield -8389.2%

SBC Impact -7453.4%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -20.9% | 100.0%

FCF 3Y | 5Y -32.6% | -18.0%

Returns

ROA -156.7%

ROE -304.9%

ROIC -359.2%

Financial Health

Net Cash

$10.8M

Current Ratio 1.76

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Quoin Pharmaceuticals, Ltd. operates as a specialized pharmaceutical firm, concentrating its efforts on devising therapeutic solutions for rare and orphan medical conditions. Its flagship offering, QR...

Sector Healthcare

Industry Biotechnology

Employees 4

IPO Date Jul 31, 2016

Website quoinpharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.